FBXL6 and colorectal carcinoma: Li et al. discovered that FBXL6 promotes the degradation of p53 through its ubiquitination at the K48 chain linkage at residues Lys291 and Lys292, which inhibits p53 signaling and thus promotes CRC cell growth [32].